Clinical trial / 2011
Acute caffeine ingestion improved flow-mediated dilation and lowered C-reactive protein in adults with and without CAD.
In a randomized trial, 40 controls and 40 adults with coronary artery disease received 200 mg caffeine or placebo on separate mornings. One hour post-ingestion, caffeine increased flow-mediated dilation in CAD patients (5.6 ± 5.0% vs 14.6 ± 5.0%) and controls (8.4 ± 2.9% vs 18.6 ± 6.8%, p < 0.001) compared to placebo. It also significantly lowered high-sensitivity C-reactive protein in both groups, without altering nitroglycerin-mediated dilation.
- Study type
- Randomized crossover trial
- Who was studied
- 80 adults (40 with stable CAD and 40 matched controls)
- What was measured
- Brachial artery flow-mediated dilation and high-sensitivity C-reactive protein
THE PAPER
Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease.
Shechter M, Shalmon G, Scheinowitz M, Koren-Morag N, Feinberg MS, Harats D, Sela BA, Sharabi Y, Chouraqui P. Am J Cardiol, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.